The global hemorrhoids treatment market size was valued at USD 1.11 billion in 2024 and is projected to grow from USD 1.19 billion in 2025 to reach USD 1.82 billion by 2033, exhibiting a CAGR of 5.5% during the forecast period (2025-2033).
The market is experiencing significant growth, driven by increased awareness of the condition and the expanding availability of treatment options. Hemorrhoids, characterized by swollen veins around the anus, can cause symptoms such as pain, itching, bleeding, and swelling. These symptoms have prompted a rising demand for effective treatments. Key drivers of market expansion include an aging population, lifestyle factors, unhealthy diets, and increasing obesity rates, all contributing to the higher incidence of hemorrhoids.
Moreover, advancements in medical technology have improved access to healthcare facilities, and the growing preference for outpatient procedures is further accelerating market growth. Ongoing research and development by major players, along with the introduction of innovative treatment options, ensure the continued evolution of the market.
Such innovations are expected to significantly contribute to market growth by providing patients with more accessible treatments, reducing the reliance on conventional methods.
The demand for advanced minimally invasive therapies for hemorrhoids is on the rise due to their benefits, such as reduced pain, quicker recovery times, and a lower risk of complications compared to conventional surgical methods. Minimally invasive treatments are becoming increasingly popular among patients who seek effective solutions with less downtime.
This growing preference for advanced treatment options, coupled with the advancement of technology, is accelerating market growth in hemorrhoid treatments as patients and healthcare providers alike opt for less invasive, more convenient alternatives.
There is a rising consumer preference for natural and over-the-counter (OTC) treatments for hemorrhoids, driven by the desire for cost-effective, non-invasive solutions. With a growing emphasis on self-care, individuals are increasingly turning to home remedies and OTC products for relief.
As consumers seek alternative options, this trend is fostering significant growth in the global hemorrhoids treatment market, aligning with the broader movement towards self-care and natural wellness.
The global prevalence of hemorrhoids is increasing, driven by lifestyle factors such as physical inactivity, poor dietary habits, obesity, and an aging population. The rising incidence of these contributing factors is leading to a higher demand for effective treatment options.
As more people experience the discomfort and complications associated with hemorrhoids, the need for accessible and efficient treatments intensifies, driving the market growth.
Increasing awareness programs and health education campaigns are essential in encouraging early diagnosis and timely treatment of hemorrhoids. As public knowledge of the condition grows, so does the demand for effective, accessible treatments.
The focus on education and prevention is expected to further stimulate the demand for hemorrhoid treatments, fueling continued growth in the market.
The high cost of advanced hemorrhoid treatments, particularly minimally invasive procedures like rubber band ligation, infrared coagulation, and stapled hemorrhoidopexy, limits patient access. These treatments require specialized equipment and skilled professionals, making them expensive and less accessible for many. Moreover, elective hemorrhoid treatments are not always fully covered by insurance, forcing patients to either bear high out-of-pocket expenses or opt for less effective home remedies and OTC solutions. This trend of self-treatment, while more affordable, can lead to complications and worsen the condition, further hindering the overall growth of the hemorrhoid treatment market.
The growing advancements in medical technologies are presenting significant opportunities in the global hemorrhoids treatment market. Innovative treatments, such as minimally invasive procedures and advanced pharmaceutical solutions, are gaining traction due to their effectiveness and reduced recovery times.
As new technologies continue to emerge, offering alternative solutions to traditional therapies, the market is expected to experience sustained growth, improving treatment accessibility and outcomes for patients worldwide.
| Study Period | 2021-2033 | CAGR | 5.5% |
| Historical Period | 2021-2023 | Forecast Period | 2025-2033 |
| Base Year | 2024 | Base Year Market Size | USD 1.11 billion |
| Forecast Year | 2033 | Forecast Year Market Size | USD 1.82 billion |
| Largest Market | North America | Fastest Growing Market | Asia Pacific |
North America remains the dominant player in the global hemorrhoids treatment market, driven by a combination of factors such as a high incidence rate of hemorrhoids, advanced healthcare infrastructure, and increasing demand for minimally invasive treatment options. The region benefits from substantial healthcare expenditure, heightened awareness of hemorrhoidal conditions, and a strong presence of key market players pushing for innovation in treatment solutions. Moreover, favorable reimbursement policies, along with a growing number of outpatient procedures, further contribute to the market's expansion.
Asia-Pacific is projected to experience the highest CAGR fueled by an increase in the prevalence of hemorrhoids, largely due to lifestyle changes, unhealthy diets, and rising obesity rates. Enhanced healthcare expenditure, coupled with growing awareness about advanced treatment options, is accelerating market growth. Moreover, the region benefits from rapid urbanization, improved healthcare infrastructure in emerging economies like China and India, and an increasing shift towards minimally invasive procedures.
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
The global hemorrhoids treatment market is segmented into type, treatment, and end-user.
The internal hemorrhoids segment holds the largest market revenue share, primarily due to their higher prevalence compared to external and prolapsed hemorrhoids. Internal hemorrhoids often go undiagnosed in their early stages as they typically don’t show noticeable symptoms, leading to a delay in treatment. As symptoms progress, the need for intervention increases.
The surgical intervention segment dominates the market for hemorrhoids treatment due to its superior effectiveness in addressing severe and recurrent cases. Surgical procedures offer sustained relief, particularly for advanced-stage hemorrhoids that don’t respond well to conservative treatments.
As more patients require surgical excision for bleeding hemorrhoids, the market’s reliance on surgical treatments continues to grow, solidifying its dominant position in the market.
Hospital segment leads market due to their advanced medical infrastructure, availability of specialist surgeons, and ability to perform complex surgical procedures. With a high volume of severe cases, hospitals are equipped to manage intensive treatments such as stapled hemorrhoidopexy and hemorrhoidectomy, which are less commonly performed in outpatient settings. Moreover, hospitals provide comprehensive post-operative care, ensuring better recovery outcomes. As a result, hospitals are the primary providers of hemorrhoid treatments, contributing to their dominance in the market and further driving market growth.
Key players in the industry are focusing on adopting key business strategies, such as strategic collaborations, product approvals, acquisitions, and product launches, to gain a strong foothold in the market. Companies are also investing heavily in research and development to introduce innovative, minimally invasive treatment solutions that improve patient outcomes.
Citius Pharmaceuticals is a U.S.-based biopharmaceutical company committed to the development and commercialization of innovative treatments for serious and unmet medical needs. By leveraging advanced research, cutting-edge technology, and rigorous clinical trials, the company aims to provide effective and safer treatment solutions across various therapeutic areas. Citius focuses on improving patient outcomes through novel drug formulations, minimally invasive therapies, and strategic collaborations.
As per our analyst, the global hemorrhoids treatment market is set for substantial expansion, driven by the increasing prevalence of hemorrhoidal disease, greater awareness of minimally invasive procedures, and rapid advancements in pharmaceutical and medical device technologies. A key trend shaping the market is the shift toward less invasive solutions, such as infrared coagulation, hemorrhoidal artery embolization, and laser therapy, which provide effective alternatives to traditional surgeries.
Moreover, the growing preference for natural remedies, including herbal and homeopathic treatments, is influencing consumer choices and expanding treatment options. Despite these opportunities, the global market faces notable challenges. High treatment costs, particularly for advanced procedures like stapled hemorrhoidopexy and rubber band ligation, limit patient access, especially in regions with inadequate healthcare reimbursement policies.
However, ongoing investments in research and development by pharmaceutical companies and medical device manufacturers are expected to drive innovation. The introduction of novel drug formulations, enhanced surgical techniques, and improved patient care strategies will continue to propel market growth, making hemorrhoid treatment more effective, accessible, and patient-friendly in the coming years.
